GreyBird Ventures

NeuroKaire develops personalized psychiatry testing tools. It uses innovative technology to predict the most effective drug treatment for patients, enabling faster recovery, fewer side effects, and lower dosing.

NeuroKaire develops personalized psychiatry testing tools. It uses innovative technology to predict the most effective drug treatment for patients, enabling faster recovery, fewer side effects, and lower dosing.

Platomics is a Vienna-based company focused on regulatory automation and the development of digital in vitro diagnostic medical devices. The company's flagship product, PlatoX, is a secure cloud platform that provides innovative software solutions and facilitates the exchange of information, products, and services within the IVD industry. Platomics specializes in creating compliant, high-performance analysis services for genetic testing, which can be utilized by manufacturers and laboratories to develop their own compliant products. The company's platform supports affected laboratories with digitization, automation, and regulatory compliance, streamlining processes for laboratories, doctors, and reagent manufacturers alike.

Angstrom Bio is a biotechnology company that applies novel nucleotide chemistry and machine learning to develop accurate and frequent diagnostic tests for diseases like COVID-19. Its technology uses nanopore sequencing and machine learning to count individual DNA molecules, aiming to minimize patient discomfort and enable repeated, high-quality testing.

GNA Biosolutions is a molecular technology company located in Martinsried, Germany, specializing in the development of innovative molecular diagnostic devices for detecting and analyzing DNA. The company utilizes its proprietary Pulse Controlled Amplification technology to enhance nucleic acid amplification and detection, featuring rapid heating and cooling rates. This advancement allows laboratories to efficiently diagnose and amplify human pathogens and DNA, simplifying the molecular testing process. GNA Biosolutions aims to make the power of molecular testing accessible to a broader audience, facilitating both laboratory and on-site applications, as well as Point of Care solutions.

Jiangxi Zhongke Jiufeng Wisdom Medical Technology Co., Ltd. was established in May 2015. Under the strong support of the Jiangxi Provincial Party Committee Government, Nanchang Municipal Government and the High-tech Zone Government, the former Siemens Northeast Asia (Greater China + Korea) Medical Mr. Wu Wenhui, the president, led the team of domestic and international first-class science and technology experts, hospital management experts and industry senior professional managers.

Ceres Nanosciences specializes in the research, development, and commercialization of innovative sample preparation products based on its proprietary Nanotrap technology. This platform captures, enriches, and preserves biomarkers from various biofluid matrices, enabling early detection of diseases such as cancer, cardiac, and infectious diseases.

Atlas5D, Inc. is a technology company dedicated to improving the quality of life for individuals with reduced mobility. Founded in 2011 and based in Cambridge, Massachusetts, the company specializes in developing and manufacturing advanced sensors that assess brain, neuromuscular, and cardiovascular conditions. Its flagship product, Echo5D, is a passive ambient sensor that unobtrusively measures human movement and behavior around the clock, without the need for wearable devices. This innovative approach allows for continuous tracking of patient ambulation and dexterity in a home environment, providing valuable insights to caregivers and healthcare professionals. Atlas5D serves diverse sectors including biotechnology, pharmaceuticals, insurance, government, and healthcare, aiming to empower patients with actionable data to monitor their health and maintain independence. The company's founders possess strong academic and professional backgrounds, notably from MIT and Harvard Medical School, and Atlas5D has been recognized as an alumnus of prestigious programs such as MassChallenge and TechStars.

Founded in 1998, Hummingbird Diagnostics develops innovative diagnostics based on miRNA biomarkers from blood. Its services include extraction, microarray, panel, validation, and bioinformatics. The company focuses on early disease detection, personalized medicine, and lifetime health monitoring.